Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Microcurrent for Fibromyalgia

NCT: NCT04949100 · ACTIVE_NOT_RECRUITING

NCT IDNCT04949100
StatusACTIVE_NOT_RECRUITING
Start Date2021-10-25
Completion2026-12
SponsorPaul Crawford (FED)
First posted
Last updated

Brief Summary

Explore the use of microcurrent therapy for fibromyalgia patients and evaluate its effect on generalized pain and quality of life. Determine if microcurrent therapy be effectively self-administered by the patient as an adjunct to medical pain management.

Frequently Asked Questions

What is Microcurrent for Fibromyalgia?

Microcurrent for Fibromyalgia is a clinical trial registered under NCT04949100. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04949100?

The current status of NCT04949100 (Microcurrent for Fibromyalgia) is: ACTIVE_NOT_RECRUITING.

When did Microcurrent for Fibromyalgia start?

Microcurrent for Fibromyalgia started on 2021-10-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.